Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Pain, Postoperative 17Breast Neoplasms 12Brain Neoplasms 11Agnosia 7Neoplasms 6Lung Neoplasms 5Delirium 5Thyroid Neoplasms 4Stomach Neoplasms 4Pituitary Neoplasms 3Pain 3Emergence Delirium 3Colorectal Neoplasms 3Chronic Pain 3Supratentorial Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Pheochromocytoma 2Pain, Intractable 2Neoplasm Metastasis 2Liver Neoplasms 2Inflammation 2Dexmedetomidine 2Colonic Neoplasms 2Central Nervous System Diseases 2Abdominal Neoplasms 2Urinary Bladder Neoplasms 1Spinal Cord Neoplasms 1Sleep Initiation and Maintenance Disorders 1Sleep Deprivation 1

Interventions

Vitamin E 1Magnetoencephalography 1Magnetic Resonance Imaging 1Fluorescein 1Enhanced Recovery After Surgery 1Eating 1Dexmedetomidine 1Bupivacaine 1Blood Specimen Collection 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Cerebrovascular Disorders × Dexmedetomidine × Clear all
NCT02878707 2020-09-22

The Neuroprotective Effects of Dexmedetomidine During Brain Surgery

National Taiwan University Hospital

Phase NA Completed
160 enrolled
CNS

Brain Neoplasms, Cerebrovascular Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡